Einhorn et al developed a prognostic score for a male with a metastatic germ cell tumor. This can help identify a patient who may benefit from high-dose chemotherapy with stem-cell rescue. The authors are from Indiana University.
Salvage chemotherapeutic regimen:
(1) carboplatin and etoposide
(2) subsequent infusion of autologous peripheral blood hematopoietic stem cells
Parameters:
(1) use of the high dose chemotherapy regimen
(2) response to previous platinum-based therapy
(3) IGCCCG prognostic group at diagnosis
Parameter |
Finding |
Points |
chemotherapy regimen |
second line |
0 |
|
third line or after |
3 |
response to previous platinum-based therapy |
responsive |
0 |
|
refractory |
2 |
initial IGCCCG group |
low or intermediate risk |
0 |
|
high risk |
2 |
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 7
• The higher the score the worse the prognosis.
Total Score |
Risk Group |
5 Year Survival |
0 |
low |
82% |
2 or 3 |
intermediate |
63% |
4, 5 or 7 |
high |
38% |
where:
• There are no combinations for 1 or 6 points.
Specialty: Hematology Oncology, Surgery, general, Urology
ICD-10: ,